BiotechTube
Home/Pipeline/SB-001

SB-001

Severe COVID‑19

PreclinicalActive

Key Facts

Indication
Severe COVID‑19
Phase
Preclinical
Status
Active
Company
AcadeMab Biomedical

About AcadeMab Biomedical

Taiwan biotech integrating antibody and mRNA‑LNP technologies to target oncology and infectious disease unmet needs.

View full company profile

Therapeutic Areas

OncologyInfectious Diseases

Other Severe COVID‑19 Drugs

DrugCompanyPhase
CBD Treatment for Severe COVID‑19Stero BiotechsPhase 1/2 completed, Phase 2b upcoming